CVAid Medical

AI-based Stroke Disease Management Platform

Health Tech & Life Sciences
Active
Series A Tel Aviv-Yafo Founded 2018
Total raised
$4.0M
Last: Series A 2022-02
Stage
Series A
Founded
2018
Headcount
4
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

CVAid focuses on the field of stroke telemedicine (telestroke), aiming to improve stroke diagnosis and spread its advanced technologies to save lives. The company offers a full-cycle stroke diagnosis and disease management platform, encompassing pre-hospital early diagnosis, in-hospital process management, and follow-up upon discharge from the hospital. The company's CVA-Flow is a comprehensive telestroke system that ensures early and accurate diagnosis of stroke by certified neurology teams using a standard smartphone and dedicated cloud servers. The CVA-Flow, supported by its artificial-intelligence module (CVA-Core), synchronizes all stroke stakeholders (e.g. patients, EMS, ER, stroke centers, medical teams, and management). CVAid uses a proprietary database of visual and auditory recordings of stroke patients, along with machine- and deep-learning tools, to create an all-in-one software solution that analyzes data in real time, providing neurologists with support tools to remotely diagnose patients without sacrificing quality.

Funding history · 2 rounds · $4.0M total

2022-02
Series A $4.0M
2022-01
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Data StorageCloudArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2C

Highlights

Verified

Tags

deep-learningalgorithmsdigital-healthcarediagnosticsdisease-managementmachine-learningcloudearly-detectionemrdoctorsmobile-applicationsdecision-supporthospitalsreal-timestrokeartificial-intelligencepatient-caremedical-technologiespatientsremote-monitoring